The chemical class of PARD6G Activators encompasses a diverse range of compounds, each uniquely influencing various cellular and biochemical pathways that intersect with the function and regulation of PARD6G. These activators do not interact directly with PARD6G but exert their influence through the modulation of signaling pathways that are either directly or indirectly related to PARD6G's role in cell polarity and signaling.
This class includes inhibitors of key signaling molecules like GSK-3β, ALK5, mTOR, ROCK, MEK, PI3K, JNK, and BMP signaling components, along with compounds that elevate intracellular cAMP levels. The mechanisms through which these chemicals influence PARD6G are varied and complex. For instance, GSK-3β inhibitors like Lithium Chloride and BIO activate the Wnt/β-catenin pathway, a key regulator of cell polarity and potentially PARD6G. Similarly, inhibitors of ALK5, such as SB-431542, modulate the TGF-beta signaling pathways, which have been implicated in the regulation of cell polarity and cytoskeletal dynamics, processes central to PARD6G's function. On the other hand, compounds like Forskolin, Rapamycin, and LY294002 act on broader cellular processes such as cAMP signaling, mTOR pathway, and PI3K pathway, respectively. These pathways play significant roles in regulating cell growth, survival, and polarity, all of which are crucial for the proper functioning of PARD6G. The indirect modulation of these pathways by the respective chemicals presents a potential route through which PARD6G activity can be influenced.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride activates the Wnt/β-catenin pathway by inhibiting GSK-3β, which may lead to the modulation of PARD6G as part of the broader Wnt signaling cascade. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A selective inhibitor of ALK5, TGFBR1, and TGFBR2, SB-431542 indirectly influences pathways related to TGF-beta signaling, which could affect PARD6G activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating cAMP levels, Forskolin can modulate various signaling pathways, potentially influencing the activity of proteins like PARD6G. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can affect cellular growth and polarity pathways, indirectly impacting PARD6G activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This ROCK inhibitor affects cytoskeletal dynamics, which might indirectly influence PARD6G activity by altering cell polarity and shape. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 can modulate stress response pathways that may intersect with PARD6G's function. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
This compound inhibits BMP signaling and could indirectly influence PARD6G activity by modulating related pathways. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A GSK-3β inhibitor known to activate the Wnt/β-catenin pathway, which could indirectly impact PARD6G. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog signaling pathway inhibitor, Cyclopamine can indirectly affect pathways that may interact with PARD6G's function. | ||||||